Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site


Click on country-registry for comparison

FlagCountry-registryRegistration periodTotal registred%No. of excluded casesIncluded cases
HVDCODCONo. follow-upOthersTotal%No.%
China - Hong Kong SAR 1996-2001992060.34.0392102626646.7925693.3
China - Qidong 1992-200071389.00.215330480.7709099.3
China - Shangai 1992-1995695913.90.032050.1695499.9
China - Tianjin 1991-1999654720.80.01201220.3652599.7
Gambia 1993-19971501.30.001262718.012382.0
India - Barshi 1993-20004883.32.110012.14797.9
India - Karunagappally 1991-19975576.41.810011.85498.2
Singapore 1993-1997165526.85.2861901056.3155093.7
Republic of Korea - Busan 1996-2001729120.210.375133078410.8650789.2
Republic of Korea - Incheon 1997-2001267220.912.73391434412.9232887.1
Republic of Korea - Seoul 1993-19971212024.313.316116352224818.5987281.5
Thailand - Chiang Mai 1993-199799342.512.0119168128829.070571.0
Thailand - Lampang 1990-2000170729.714.72511025214.8145585.2
Thailand - Songkhla 1990-199938352.09.13577011229.227170.8
Uganda - Kampala 1993-199713336.10.81881712.811687.2
Zimbabwe - Harare 1993-199714920.110.716101711.413288.6



Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period